Clinical Trials
Real innovation starts with real people. Our doctors and researchers never stop working to advance medicine that improves healthcare for all. One way we do so is through clinical studies that explore new drugs, therapies, medical devices and clinical and surgical methods. Be part of medicine's evolution by participating in a clinical trial at Tufts Medicine.
Find a clinical trial
Dr checking a patient

Why participate in a clinical trial?

Healthcare isn't a one-size-fits all approach, and sometimes known treatments today aren't always the best fit for your care plan. Clinical trials offer new, experimental therapies for conditions that haven't always responded to more traditional treatment approaches. 

People without any health concerns are welcome to join studies, too. If you're looking to better understand diseases and treatments that can help today’s patients and future generations, talk with your primary care doctor about participating in a clinical trial. 

Search for our open clinical trials by condition, disease, age, gender and ailment.

Is your company seeking a research study site?

Discover what Tufts Medicine can offer.

Contact the clinical trials office
 

Plan before participating

Clinical studies further explore new drugs, therapies, medical devices and clinical and surgical methods. Before participating, make sure to:

  • Talk with your doctor about how participating in a clinical trial can impact your care plan
  • Review eligibility criteria for each clinical trial
  • Understand the risks of participating in experimental therapies

Our open clinical trials

 See more related content
A multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on the progression of calcific aortic valve stenosis
medical-cross
Aortic stenosis
user
All genders
person-wave 50+
world
Recruiting now
Learn more

Research success stories
New treatment for brain cancer found to increase median life expectancy by nearly 40%
Despite lacking a complete cure for the deadly disease, promising research offers a new line of hope for people living with glioblastoma by potentially extending life expectancies.

“This is the first time in nearly 20 years that a phase III trial of a systemic treatment has shown extended survival for glioblastoma patients,” said study co-author Julian K. Wu, MD, Associate Chairman of the Department of Neurosurgery and Chief of Neurosurgical Oncology at Tufts Medical Center, and the Principal Investigator for the Tufts MC trial site.
Dr taking notes with patient

Is there a clinical trial right for you?

Discover all clinical trials Tufts Medicine is actively recruiting for, and check back regularly for new opportunities.